POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,772 | -28.7% | 21,705 | -3.1% | 0.11% | -26.5% |
| Q2 2023 | $202,989 | -2.1% | 22,405 | -18.2% | 0.15% | -6.8% |
| Q1 2023 | $207,267 | -20.8% | 27,380 | -23.7% | 0.16% | -26.7% |
| Q4 2022 | $261,747 | -5.2% | 35,905 | +0.6% | 0.22% | -14.0% |
| Q3 2022 | $276,000 | +1.8% | 35,705 | -4.1% | 0.26% | +16.8% |
| Q2 2022 | $271,000 | +0.7% | 37,230 | +10.3% | 0.22% | +7.8% |
| Q1 2022 | $269,000 | +51.1% | 33,750 | +6.5% | 0.20% | +53.4% |
| Q4 2021 | $178,000 | – | 31,700 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,560,984 | $27,526,000 | 6.63% |
| Fairmount Funds Management LLC | 2,833,950 | $21,906,000 | 3.85% |
| JOHNSON & JOHNSON | 1,000,000 | $7,730,000 | 2.28% |
| BVF INC/IL | 5,590,048 | $43,211,000 | 1.78% |
| Affinity Asset Advisors, LLC | 746,576 | $5,771,000 | 1.61% |
| Sio Capital Management, LLC | 544,545 | $4,209,000 | 1.34% |
| PFM Health Sciences, LP | 4,515,216 | $34,903,000 | 1.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,052,842 | $8,138,000 | 1.13% |
| Boxer Capital, LLC | 2,500,000 | $19,325,000 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $2,319,000 | 0.78% |